Chat with us, powered by LiveChat

 Speaker Profile

M.D., Professor, Mayo Clinic

Biography
For over 40 years, John D. Halamka, M.D., M.S., has been dedicated to the technology and policy that enable information exchange among clinical, educational and administrative stakeholders. In particular, Dr. Halamka is focused on bringing people together for multidisciplinary collaboration and career development at all levels. He works across government, academia and industry to form consortia that accelerate progress in informatics and patient care. As Dwight and Dian Diercks President of the Mayo Clinic Platform, Dr. Halamka is currently collaborating with Young J. Juhn, M.D., M.P.H., on research addressing algorithmic bias. This work has profound implications for artificial intelligence (AI) research and health equity and is a high priority of the Mayo Clinic Platform and Mayo Clinic as a whole. Dr. Halamka also is dedicated to educating the next generation of health care technology professionals. His expertise has given him the opportunity to teach extraordinarily diverse audiences, ranging from medical students to international policymakers. Before transitioning to Mayo Clinic, he served as a professor at Harvard Medical School for 25 years. Dr. Halamka's research and clinical background, combined with his passion for teaching, have enabled him to implement innovative technologies in local, regional, national and international settings. During the COVID-19 pandemic, he served as co-leader of the COVID-19 Healthcare Coalition and the national convalescent plasma effort, The Fight Is In Us. He also was an active participant in Harvard's Clinical and Translational Science Awards program and was the co-principal investigator of Harvard's i2b2 project and Harvard Catalyst efforts.


 Session Abstract – PMWC 2027 Silicon Valley

Track 1: Next-Gen Tx - Jan 28 9.00 A.M.-5.00 P.M.


Track Chair:
Razelle Kurzrock, Emory

PMWC Award Ceremony
• Antoni Ribas, UCLA Health (Luminary)

Featured Speakers
• Antoni Ribas, UCLA Health
• Gerold Meinhardt, Daiichi Sankyo
• Katy Rezvani, MD Anderson
• Javad Shahidi, BeOne
• Alicia Zhou, Cancer Research Institute
• Oren Gilad, Aprea Therapeutics
• Adam Palmer, UNC
• Trever Bivona, UCSF
• Laura Volta, Penn Medicine
• Vivek Subbiah, Stanford
• Mark Stewart, Friends of Cancer Research

Precision Immunotherapy After PD-1
Cells, bispecifics, ADCs, and new combination logic after checkpoint failure.

Biomarkers That Matter
Selecting patients for immunotherapy and targeted therapy with decision-grade biomarkers.

Resistance Biology & Adaptive Combination Strategies
How tumors adapt, and how to sequence therapy around that biology.

Which Immune Cells Can Be Programmed In Vivo?
The next wave of immune-cell engineering and where it may matter first.

Rare Cancers, Basket Trials & N-of-1 Playbooks
Moving from histology-agnostic evidence to individualized precision oncology.

PMWC 2027 Silicon Valley - Program

PMWC Hall of Impact

Previous Speakers Include

Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.

×

Add Names/PO on Receipt

Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required

Apply to Speak at PMWC Silicon Valley by AUG. 27TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.